Publicaciones en las que colabora con MIGUEL ÁNGEL LÓPEZ NEVOT (30)

2022

  1. HLA Class II Polymorphism and Humoral Immunity Induced by the SARS-CoV-2 mRNA-1273 Vaccine

    Vaccines, Vol. 10, Núm. 3

  2. Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients

    International Journal of Molecular Sciences, Vol. 23, Núm. 13

  3. Study of HLA-A, -B, -C, -DRB1 and -DQB1 polymorphisms in COVID-19 patients

    Journal of Microbiology, Immunology and Infection, Vol. 55, Núm. 3, pp. 421-427

2016

  1. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: The influence of human leucocyte antigen alleles

    Pharmacogenetics and Genomics, Vol. 26, Núm. 9, pp. 414-422

  2. Killer immunoglobulin-like receptor profiles are not associated with risk of amoxicillin-clavulanate-induced liver injury in Spanish patients

    Frontiers in Pharmacology, Vol. 7, Núm. AUG

2014

  1. Erratum: HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity (PLoS ONE (2014) 9:10 (e112165))

    PLoS ONE

2013

  1. HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity

    PLoS ONE, Vol. 8, Núm. 7

2007

  1. Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours

    Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226

  2. MHC Class I Antigens and Immune Surveillance in Transformed Cells

    International Review of Cytology, Vol. 256, pp. 139-189

  3. Monoclonal TCR-Vβ13.1+/CD4+/NKa +/CD8-/+dim T-LGL lymphocytosis: Evidence for an antigen-driven chronic T-cell stimulation origin

    Blood, Vol. 109, Núm. 11, pp. 4890-4898

2005

  1. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity

    Cancer Immunology, Immunotherapy, Vol. 54, Núm. 2, pp. 141-148

2003

  1. Analysis of HLA expression in human tumor tissues

    Cancer Immunology, Immunotherapy, Vol. 52, Núm. 1, pp. 1-9

2002

  1. Impaired surface antigen presentation in tumors: Implications for T cell-based immunotherapy

    Seminars in Cancer Biology, Vol. 12, Núm. 1, pp. 15-24

2001

  1. A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-a*0301 allele in a prostate carcinoma cell line

    Immunogenetics, Vol. 53, Núm. 7, pp. 606-610

2000

  1. β2-Microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

    International Journal of Clinical and Laboratory Research, Vol. 30, Núm. 2, pp. 87-92

1998

  1. Mutations of the β2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

    Tissue Antigens, Vol. 52, Núm. 6, pp. 520-529

1995

  1. Hla Class I Antigens in Human Tumors

    Advances in Cancer Research, Vol. 67, Núm. C, pp. 155-195

1990

  1. Class II HLA Antigen Expression in Familial Polyposis Coli is Related to the Degree of Dysplasia

    Immunobiology, Vol. 180, Núm. 2-3, pp. 138-148

  2. The monoclonal antibody GRC1 produced against human cornea recognizes a common determinant of collagen

    Investigative Ophthalmology and Visual Science, Vol. 31, Núm. 2, pp. 290-293

1989

  1. Different CD45 and CD45R epitopes involved in T cell proliferation and NK cytotoxicity

    Hybridoma, Vol. 8, Núm. 1, pp. 1-11